Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Cancer. 2015 Jul 15;137(2):320-31. doi: 10.1002/ijc.29396. Epub 2015 Jan 20.

Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas.

Author information

  • 1Institute of Human Genetics, University of Bonn, Bonn, Germany.
  • 2Cologne Center for Genomics, University of Cologne, Cologne, Germany.
  • 3Institute of Human Genetics, University of Cologne, Cologne, Germany.
  • 4Department of Genetics, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, USA.
  • 5MVZ Dr. Eberhard & Partner, Dortmund, Germany.
  • 6Medizinische Klinik-Campus Innenstadt, Klinikum der LMU, Munich, Germany.
  • 7MGZ-Center of Medical Genetics, Munich, Germany.
  • 8Medizinische Klinik 1, Biomedical Research Laboratory, University of Frankfurt, Frankfurt, Germany.
  • 9Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
  • 10Division of Medical Genetics, University Hospital Basel and Department of Biomedicine, University of Basel, Basel, Switzerland.

Abstract

In a number of families with colorectal adenomatous polyposis or suspected Lynch syndrome/HNPCC, no germline alteration in the APC, MUTYH, or mismatch repair (MMR) genes are found. Missense mutations in the polymerase genes POLE and POLD1 have recently been identified as rare cause of multiple colorectal adenomas and carcinomas, a condition termed polymerase proofreading-associated polyposis (PPAP). The aim of the present study was to evaluate the clinical relevance and phenotypic spectrum of polymerase germline mutations. Therefore, targeted sequencing of the polymerase genes POLD1, POLD2, POLD3, POLD4, POLE, POLE2, POLE3 and POLE4 was performed in 266 unrelated patients with polyposis or fulfilled Amsterdam criteria. The POLE mutation c.1270C>G;p.Leu424Val was detected in four unrelated patients. The mutation was present in 1.5% (4/266) of all patients, 4% (3/77) of all familial cases and 7% (2/30) of familial polyposis cases. The colorectal phenotype in 14 affected individuals ranged from typical adenomatous polyposis to a HNPCC phenotype, with high intrafamilial variability. Multiple colorectal carcinomas and duodenal adenomas were common, and one case of duodenal carcinoma was reported. Additionally, various extraintestinal lesions were evident. Nine further putative pathogenic variants were identified. The most promising was c.1306C>T;p.Pro436Ser in POLE. In conclusion, a PPAP was identified in a substantial number of polyposis and familial colorectal cancer patients. Screening for polymerase proofreading mutations should therefore be considered, particularly in unexplained familial cases. The present study broadens the phenotypic spectrum of PPAP to duodenal adenomas and carcinomas, and identified novel, potentially pathogenic variants in four polymerase genes.

© 2014 UICC.

KEYWORDS:

Lynch syndrome; adenomatous polyposis; familial colorectal cancer; gastrointestinal polyposis syndromes; next-generation sequencing

PMID:
25529843
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk